Medivate Partners
Finance · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15f Kwangil Seocho Gu Plz 331, Seoul, 06...Phone Number
+82 25360704Website
www.medivatepartners.comRevenue
$6.6 MillionIndustry
About Medivate Partners
Medivate Partners Org Chart
Is Medivate Partners your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Medivate Partners launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Medivate Partners, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Medivate Partners has new funding data
Check out if Medivate Partners is spiking on competitors!
Click to see if Medivate Partners had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Medivate Partners
Check if Medivate Partners has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Medivate Partners recently announced quarterly report
Recommended Actions
Find VP level buyers at Medivate Partners
Find more new buyers
Company Profile Activity
Activity Insights
Medivate Partners is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Medivate Partners is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Medivate Partners.
Medivate Partners Tech Stack
A closer look at the technologies used by Medivate Partners
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medivate Partners
Medivate, is a private equity and venture capital firm that focuses investment in biotech/healthcare industry in Asia and North America. The firm is well positioned to capture surging healthcare investment opportunities between Asia and North America, and looks to arbitrage the unique cross border investment advantages. While closing its third fund... Read More